Exact Sciences Corporation

Healthcare · Diagnostics & Research · United States

Last price 104.91 USD (At close: Mar 20, 2026) · Market cap 20.03B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; Oncodetect Test;OncoExTra Test for tumor profiling for patients...